Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling
Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling. // Experimental Cell Research. – URL: https://www.sciencedirect.com/science/article/pii/S0014482726003083?dgcid=rss_sd_all
Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling. Experimental Cell Research. https://www.sciencedirect.com/science/article/pii/S0014482726003083?dgcid=rss_sd_all
“Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling.” Experimental Cell Research.
@article{article3397,
title = {Liquiritigenin attenuates inflammatory periapical bone loss by stabilizing TRIM31 and restraining NLRP3 inflammasome and cGAS-STING inflammatory signaling},
journal = {Experimental Cell Research},
url = {https://www.sciencedirect.com/science/article/pii/S0014482726003083?dgcid=rss_sd_all}
}